 We propose to perform a clinical randomized trial to evaluate the effect of blastocyst biopsy and whole chromosome analysis by Next Generation Sequencing NGS in comparison to standard Assisted Reproductive Technologies ART methods on on implantation rates, miscarriage rates, and pregnancy rates. 